Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Completed

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

NCT05451212

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +19 more
Locations
  • UC Irvine, Department of Neurology Orange, California, United States
  • UC Davis, Department of Neurology Sacramento, California, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Oregon Health & Science University (OHSU) Portland, Oregon, United States
View Trial Details
Completed

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

NCT05681715

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0020 50092 Orange, California, United States
  • Mg0020 50099 San Francisco, California, United States
  • Mg0020 50561 Lexington, Kentucky, United States
  • Mg0020 50090 Winston-Salem, North Carolina, United States
View all 27 locations
View Trial Details
Completed

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

NCT05514873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0017 50564 Scottsdale, Arizona, United States
  • Mg0017 50559 Los Angeles, California, United States
  • Mg0017 50593 Rancho Mirage, California, United States
  • Mg0017 50099 San Francisco, California, United States
View Trial Details

Related conditions